M Aardoom

First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised controlled trial

M Jongsma, M Aardoom, Martinus A. Cozijnsen et al. · Gut · 2020 · 118 citations · Full text

Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: A randomized controlled trial with at least 5-year follow-up

Marieke H. Roozeboom, M Aardoom, Patty J. Nelemans et al. · Journal of the American Academy of Dermatology · 2013 · 101 citations

Photodynamic Therapy, Versus Surgical Excision, Least 5-Year Follow-up +3

Malignancy and mortality in paediatric‐onset inflammatory bowel disease: a 3‐year prospective, multinational study from the paediatric <scp>IBD</scp> Porto group of <scp>ESPGHAN</scp>

Maria E. Joosse, M Aardoom, Polychronis Kemos et al. · Alimentary Pharmacology & Therapeutics · 2018 · 53 citations · Full text

Vedolizumab Trough Levels in Children With Anti‐Tumor Necrosis Factor Refractory Inflammatory Bowel Disease

M Aardoom, M Jongsma, Annick de Vries et al. · Journal of Pediatric Gastroenterology and Nutrition · 2020 · 17 citations · Full text

High Impact of Pediatric Inflammatory Bowel Disease on Caregivers’ Work Productivity and Daily Activities: An International Prospective Study

R Klomberg, M Aardoom, Polychronis Kemos et al. · The Journal of Pediatrics · 2022 · 17 citations · Full text